Souhaitez-vous accéder aux communiqués récents ?

SAN DIEGO, CA, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Sapu Bioscience today announced advancements in its global IP portfolio supporting OT-101, its proprietary TGF-β antisense therapeutic platform,...

LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) and Sapu Bioscience today announced key advancements in its global intellectual...

Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis

Material Transfer and Evaluation Agreement (MTEA) to initiate a collaboration focused on siRNA delivery for central nervous system (CNS) disorders.

SAN FRANCISCO and BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to...

Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, has opened its new clinic in Plano, Texas.

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today...

Bexorg strengthens leadership team with appointment of Sean Murphy, Ph.D., as Chief Technology Officer

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline...

Avance Clinical today announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.